One Year Cross-Sectional Study of Association Between Androgenetic Alopecia and Benign Prostatic Hyperplasia in a Tertiary Care Hospital

    Prarthana B Desai, Krishna B S Swamy, RB Nerli
    TLDR There is no link between hair loss and prostate enlargement.
    The study conducted at a tertiary care hospital aimed to analyze the association between androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH) in male patients aged 25-45 years. Over the course of one year, 64 patients with AGA were evaluated using the Modified Hamilton-Norwood Classification, transabdominal ultrasonogram, and serum prostate-specific antigen (PSA) level estimation. The results showed that 39.1% of patients had Grade III AGA, 32.8% had Grade IV, 25% had Grade V, and 3.1% had Grade VI. Despite observing an increase in prostate volume among AGA patients, the study concluded that there was no association between AGA, prostate volume, and serum PSA levels.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  40 upvotes 5 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community What an amazing time to be alive

      in Finasteride/Dutasteride  187 upvotes 1 year ago
      The post discusses a user's experience with hair loss treatments, specifically topical finasteride, minoxidil, and micro-needling, and their plan to switch to oral versions and add Dutasteride. The conversation includes various responses, with some users sharing their own experiences and side effects, and others expressing desire for a more permanent hair loss solution.

      community 1 month of using fin, so happy

      in Progress Pictures  866 upvotes 10 months ago
      User had a hair transplant and used a finasteride and minoxidil spray for 6 months with no results. After adding finasteride tablets for 1 month, they saw significant hair growth improvement.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 10 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

    Related Research

    3 / 3 results